Donepezil: Difference between revisions

From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs)
No edit summary
David Canner (talk | contribs)
No edit summary
Line 21: Line 21:
! [[Rivastigmine]]
! [[Rivastigmine]]
! [[Galantamine]]
! [[Galantamine]]
! [[Metrifonate]]
|-
|-
! [[Pharmaceutical_Drugs#Tmax|T<sub>max</sub>]] (hr)  
! [[Pharmaceutical_Drugs#Tmax|T<sub>max</sub>]] (hr)  
Line 28: Line 27:
! .3
! .3
! 1.2
! 1.2
! .5
|-
|-
! [[Pharmaceutical_Drugs#Cmax|C<sub>max</sub>]] (ng/ml)  
! [[Pharmaceutical_Drugs#Cmax|C<sub>max</sub>]] (ng/ml)  
Line 35: Line 33:
! 29.3
! 29.3
! 42.6
! 42.6
! 543
|-
|-
! [[Pharmaceutical_Drugs#Bioavailability_.28F.29|Bioavailability]] (%)
! [[Pharmaceutical_Drugs#Bioavailability_.28F.29|Bioavailability]] (%)
Line 42: Line 39:
! 36
! 36
! 100
! 100
! 90
|-
|-
! [[Pharmaceutical_Drugs#Protein_Binding|Protein Binding]] (%)
! [[Pharmaceutical_Drugs#Protein_Binding|Protein Binding]] (%)
Line 49: Line 45:
! 40
! 40
! 10
! 10
! 20
|-
|-
! [[Pharmaceutical_Drugs#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
! [[Pharmaceutical_Drugs#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
Line 56: Line 51:
! 5
! 5
! 7.3
! 7.3
! 2
|-
|-
! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
Line 63: Line 57:
! 191
! 191
! 427
! 427
! 89.2
|-
|-
! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
! [[Pharmaceutical_Drugs#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
! 53.6
! 6.7 (Rat)
! 450
! 450 (Human)
! 181390
! 181390 (Rat)
! 1995
! 1995 (Rat)
! 1080
|-
|-
! Dosage (mg)
! Dosage (mg)
Line 77: Line 69:
! 6
! 6
! 8
! 8
! 30
|-
|-
! Metabolism
! Metabolism
! Hepatic (CYP2D6 & CYP3A4)
! Hepatic (CYP2D6 & CYP3A4)
! [[Tacrine]]
! Hepatic (CYP1A2)
! [[Rivastigmine]]
! Cholinesterase
! [[Galantamine]]
! Hepatic (CYP3A4 & CYP2D6) & Cholinesterase
! [[Metrifonate]]
|}
|}